152 related articles for article (PubMed ID: 26734002)
1. Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis.
Lorenzen E; Follmann F; Bøje S; Erneholm K; Olsen AW; Agerholm JS; Jungersen G; Andersen P
Front Immunol; 2015; 6():628. PubMed ID: 26734002
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted
Wern JE; Sorensen MR; Olsen AW; Andersen P; Follmann F
Front Immunol; 2017; 8():569. PubMed ID: 28567043
[TBL] [Abstract][Full Text] [Related]
3. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
5. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
Li Z; Wang S; Wu Y; Zhong G; Chen D
Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
[TBL] [Abstract][Full Text] [Related]
6. Genital Infiltrations of CD4
Erneholm K; Lorenzen E; Bøje S; Olsen AW; Jungersen G; Jensen HE; Cassidy JP; Andersen P; Agerholm JS; Follmann F
Front Microbiol; 2019; 10():197. PubMed ID: 30800114
[TBL] [Abstract][Full Text] [Related]
7.
Shillova N; Howe SE; Hyseni B; Ridgell D; Fisher DJ; Konjufca V
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33139380
[No Abstract] [Full Text] [Related]
8. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.
Kuczkowska K; Myrbråten I; Øverland L; Eijsink VGH; Follmann F; Mathiesen G; Dietrich J
PLoS One; 2017; 12(5):e0176401. PubMed ID: 28467432
[TBL] [Abstract][Full Text] [Related]
10. Multi-component prime-boost
Lorenzen E; Contreras V; Olsen AW; Andersen P; Desjardins D; Rosenkrands I; Juel HB; Delache B; Langlois S; Delaugerre C; Joubert C; Dereuddre-Bosquet N; Bébéar C; De Barbeyrac B; Touati A; McKay PF; Shattock RJ; Le Grand R; Follmann F; Dietrich J
Front Immunol; 2022; 13():1057375. PubMed ID: 36505459
[TBL] [Abstract][Full Text] [Related]
11. Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis.
Garcia-Del Rio L; Diaz-Rodriguez P; Pedersen GK; Christensen D; Landin M
Adv Healthc Mater; 2022 Jun; 11(11):e2102508. PubMed ID: 35124896
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.
Nogueira CV; Zhang X; Giovannone N; Sennott EL; Starnbach MN
J Immunol; 2015 Mar; 194(5):2319-29. PubMed ID: 25637024
[TBL] [Abstract][Full Text] [Related]
13. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
14. Preclinical screen for protection efficacy of chlamydial antigens that are immunogenic in humans.
Lu C; Wang J; Zhong G
Infect Immun; 2023 Nov; 91(11):e0034923. PubMed ID: 37889004
[TBL] [Abstract][Full Text] [Related]
15. Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization.
Schautteet K; De Clercq E; Jönsson Y; Lagae S; Chiers K; Cox E; Vanrompay D
Vaccine; 2012 Apr; 30(18):2869-81. PubMed ID: 22387629
[TBL] [Abstract][Full Text] [Related]
16. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
[TBL] [Abstract][Full Text] [Related]
17. Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model.
Olsen AW; Andersen P; Follmann F
Vaccine; 2014 Feb; 32(6):685-92. PubMed ID: 24365515
[TBL] [Abstract][Full Text] [Related]
18. Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs.
Wali S; Gupta R; Yu JJ; Lanka GKK; Chambers JP; Guentzel MN; Zhong G; Murthy AK; Arulanandam BP
Immunol Cell Biol; 2017 May; 95(5):454-460. PubMed ID: 27990018
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.
Cong Y; Jupelli M; Guentzel MN; Zhong G; Murthy AK; Arulanandam BP
Vaccine; 2007 May; 25(19):3773-80. PubMed ID: 17349723
[TBL] [Abstract][Full Text] [Related]
20. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
Murthy AK; Cong Y; Murphey C; Guentzel MN; Forsthuber TG; Zhong G; Arulanandam BP
Infect Immun; 2006 Dec; 74(12):6722-9. PubMed ID: 17015458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
